Fundz

Ridge Biotechnologies raises $25 million in seed financing to enhance AI-enabled precision enzyme and drug design, led by Sutter Hill Ventures.

PRIVATESep 09, 2025

Amount Raised

$25 Million

Round Type

Seed

Palo AltoBiotechnologyHealth CareArtificial Intelligence

Investors

Overlap HoldingsSutter Hill Ventures

Description

Ridge Biotechnologies has emerged from stealth with an oversubscribed $25 million in seed financing. The round was led by Sutter Hill Ventures, with participation from Overlap Holdings. The funding will support the rollout of its NativeLink and ProTrigger products. Ridge Bio aims to develop cutting-edge therapeutics using machine learning and bioengineering.

Who else raised in Biotechnology and Health Care around the same time

Companies in the same sectors as Ridge Biotechnologies that raised within 45 days of this round, from Fundz verified event records.

  • Synaptrix Labs raised an undisclosed amount (Seed) on October 24, 2025.
  • Spectral AI raised $7.6M (Funding Round) on October 23, 2025.
  • Moberg Analytics raised $600K on October 20, 2025.
  • WellTheory raised $14M (Series A) on October 14, 2025.
  • Alleviate Health raised $4.3M (Seed) on October 13, 2025.
  • Nerveli raised $540K (Pre-Seed) on October 9, 2025.

Who to call at Ridge Biotechnologies, and when

A new round usually means Ridge Biotechnologies is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Ridge Biotechnologies raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Ridge Biotechnologies, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Ridge Biotechnologies. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Ridge Biotechnologies

Location

755 Page Mill Rd.

Palo Alto, California, United States

About

Ridge Biotechnologies is a pioneering company focused on AI-enabled precision enzyme and targeted drug design. The company aims to revolutionize drug development through advanced machine learning and bioengineering techniques. Their innovative platform enables the design of therapeutics that address complex drug development challenges, promising safer and more precise medicines. Ridge Bio has launched products such as NativeLink and ProTrigger, enhancing therapeutic applications in antibody-drug conjugates.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Ridge Biotechnologies raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsRomas, VP of ADCsSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Ridge Biotechnologies's next move

See what Strategic adds

Ridge Biotechnologies raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.